NCT01101178View on ClinicalTrials.gov

To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 80-mg tablet x 1 dose taken with food.

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 80-mg tablet x 1 dose taken with food.

Trial Locations (1)

53704

Covance Clinical Research Unit Madison, Madison

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01101178 - To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter